Health Condition 1: B338- Other specified viral diseases
Conditions
Interventions
Intervention1: AYSUH 64/Kabasura Kudineer: AYUSH 64-
Asymptomatic -2-0-2 for 20 days
Mild/moderate 2-2-2 for 20 days
Kabasura Kudineer
60 ml twice daily for 20 days
Control Intervention1: NA: NA
Sponsors
Ministry of AYUSH Govt of India
Eligibility
Inclusion criteria
Inclusion criteria: • Individuals of any gender within the age group 18-60 years • Individuals diagnosed as COVID 19 and categorized as asymptomatic, mild or moderate disease • within • Patients in home isolation under standard care as per the government guidelines • Patients providing informed consent and willing to participate in the clinical study
Exclusion criteria
Exclusion criteria: • Patients not willing to use the Ayush interventions(AYUSH-64 &KabasuraKudineer) • Pregnant, lactating women and other vulnerable population • Use of immunosuppressive doses of corticosteroids prior to the enrollment in the study and planned use of immunosuppressive doses of corticoids • Any other condition that, in the opinion of the principal investigator or his/her representative physician, could put the safety of potential participants at risk or prevent them from complying with this protocol. • Patients who were diagnosed as having severe disease or receiving oxygen support. • People who are unable to take oral medication • People whose SpO2 levels are fluctuating within the range of 90-94.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Demographic profiling of COVID 19 patients in home isolation, who received Ayush interventions(AYUSH 64 / Kabasurakudineer) as adjunct to standard care for asymptomatic, mild, and moderate COVID 19 in terms of geographic location, age, gender, education status, and domicile, based on the data reported through the Ayush Sanjivani appTimepoint: Day 1, Day 20 | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Assessment of compliance in the patients who were issued with AYUSH 64/Kabasura KudineerTimepoint: Day 1, Day 20;â?¢ Documentation of patients perception on the benefit obtained by use of AYUSH interventions(AYUSH 64 / Kabasurakudineer) through self reported change in appetite, bowel habits, sleep, and physical health as reported through Ayush Sanjivani appTimepoint: Day 1, Day 20;â?¢ Mean duration of the time taken for clinical recovery (symptom free in the last 48 hours) as reported by the patients.Timepoint: Day 1, Day 20;â?¢ Proportion of COVID 19 patients in home isolation, who received Ayush interventions (AYUSH 64 / Kabasurakudineer) as adjunct to standard care for asymptomatic, mild, and moderate COVID 19, across IndiaTimepoint: DAY 1, Day 20;â?¢ Proportion of patients who reported any AE during the use of the medicineTimepoint: Day 1, Day 20;â?¢ Proportion of patients who required hospitalizationTimepoint: Day 1, Day 20;â?¢ Proportion of patients who required oxygen supportTimepoint: Day 1, Day 20;â?¢ Proportion of patients who required ventilator supportTimepoint: Day 1, Day 20;â?¢ Proportion of patients who underwent progression of disease to severeTimepoint: Day 20 | — |
Countries
India
Contacts
Public ContactDr Narayanam Srikanth
Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Govt.of India
Outcome results
None listed